Helen Stephenson-Ellis
Corporate Officer/Principal bij Chartered Institute of Personnel & Development
Actieve functies van Helen Stephenson-Ellis
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Chartered Institute of Personnel & Development | Corporate Officer/Principal | - | - |
Loopbaan van Helen Stephenson-Ellis
Eerdere bekende functies van Helen Stephenson-Ellis
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| OXFORD BIOMEDICA PLC | Human Resources Officer | 03-04-2018 | 01-05-2022 |
| VERNALIS | Human Resources Officer | - | - |
Medimmune UK Ltd.
 Medimmune UK Ltd. Chemicals: Major DiversifiedProcess Industries Medimmune UK Ltd. manufactures chemical products. The company was founded on October 6, 1999 and is headquartered in Speke, the United Kingdom. | Human Resources Officer | - | - |
| ASTRAZENECA PLC | Human Resources Officer | - | - |
Opleiding van Helen Stephenson-Ellis
| University of Northumbria | Undergraduate Degree |
Statistieken
Internationaal
| Verenigd Koninkrijk | 7 |
Operationeel
| Human Resources Officer | 4 |
| Undergraduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| OXFORD BIOMEDICA PLC | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Medimmune UK Ltd.
Medimmune UK Ltd. Chemicals: Major DiversifiedProcess Industries Medimmune UK Ltd. manufactures chemical products. The company was founded on October 6, 1999 and is headquartered in Speke, the United Kingdom. | Process Industries |
Ligand UK Ltd.
 Ligand UK Ltd. Pharmaceuticals: MajorHealth Technology Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1988 and is headquartered in Winnersh, the United Kingdom. | Health Technology |
